<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	xmlns:georss="http://www.georss.org/georss" xmlns:geo="http://www.w3.org/2003/01/geo/wgs84_pos#" xmlns:media="http://search.yahoo.com/mrss/"
	>

<channel>
	<title>The Regeneration Station &#187; cell delivery</title>
	<atom:link href="http://regeneration-station.com/category/cell-delivery/feed/" rel="self" type="application/rss+xml" />
	<link>http://regeneration-station.com</link>
	<description>Stem cells, biomaterials, engineered tissues, and other cell-based technologies.  The guts of the Regenerative Medine industry.</description>
	<lastBuildDate>Thu, 27 Oct 2011 11:43:42 +0000</lastBuildDate>
	<language>en</language>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>1</sy:updateFrequency>
	<generator>http://wordpress.com/</generator>
<cloud domain='regeneration-station.com' port='80' path='/?rsscloud=notify' registerProcedure='' protocol='http-post' />
<image>
		<url>http://s2.wp.com/i/buttonw-com.png</url>
		<title>The Regeneration Station &#187; cell delivery</title>
		<link>http://regeneration-station.com</link>
	</image>
	<atom:link rel="search" type="application/opensearchdescription+xml" href="http://regeneration-station.com/osd.xml" title="The Regeneration Station" />
	<atom:link rel='hub' href='http://regeneration-station.com/?pushpress=hub'/>
		<item>
		<title>Cytori Announces Progress in Cardiac Regeneration Clinical Studies</title>
		<link>http://regeneration-station.com/2008/02/01/cytori-announces-progress-in-cardiac-regeneration-clinical-studies/</link>
		<comments>http://regeneration-station.com/2008/02/01/cytori-announces-progress-in-cardiac-regeneration-clinical-studies/#comments</comments>
		<pubDate>Thu, 31 Jan 2008 19:29:04 +0000</pubDate>
		<dc:creator>jrowley</dc:creator>
				<category><![CDATA[adult stem cell]]></category>
		<category><![CDATA[autologous]]></category>
		<category><![CDATA[Bioprocessing]]></category>
		<category><![CDATA[cardiac regeneration]]></category>
		<category><![CDATA[cell delivery]]></category>
		<category><![CDATA[Clinical Trials]]></category>
		<category><![CDATA[Company Profiles]]></category>
		<category><![CDATA[Cytori]]></category>
		<category><![CDATA[Device-centric cell therapies]]></category>
		<category><![CDATA[patient specific cell therapy]]></category>
		<category><![CDATA[personalized medicine]]></category>
		<category><![CDATA[Regenerative Medicine]]></category>
		<category><![CDATA[stem cells]]></category>

		<guid isPermaLink="false">http://regenerationstation.wordpress.com/?p=77</guid>
		<description><![CDATA[Cytori Therapeutics announced that they have enrolled their first two patients in an acute myocardial infarction clinical trial using adipose-derived cells prepared using their Celution™ device. The Celution™ device is an automated, tissue processing unit that isolates cells from adipose tissue derived via liposuction. The cells are then available for transplantation back into the patient [...]<img alt="" border="0" src="http://stats.wordpress.com/b.gif?host=regeneration-station.com&amp;blog=2140418&amp;post=77&amp;subd=regenerationstation&amp;ref=&amp;feed=1" width="1" height="1" />]]></description>
		<wfw:commentRss>http://regeneration-station.com/2008/02/01/cytori-announces-progress-in-cardiac-regeneration-clinical-studies/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
	
		<media:content url="http://0.gravatar.com/avatar/0d9b2076a0e9ca10c6e79a0e41a6caea?s=96&#38;d=identicon&#38;r=G" medium="image">
			<media:title type="html">jrowley</media:title>
		</media:content>

		<media:content url="http://regenerationstation.files.wordpress.com/2008/01/cytoriii.png" medium="image">
			<media:title type="html">cytoriii.png</media:title>
		</media:content>

		<media:content url="http://regenerationstation.files.wordpress.com/2008/01/cytori.png" medium="image">
			<media:title type="html">cytori.png</media:title>
		</media:content>
	</item>
		<item>
		<title>Pervasis Advances Tissue Engineered Products for Vascular Health</title>
		<link>http://regeneration-station.com/2008/01/22/pervasis-furthers-tissue-engineered-products-for-vascular-health/</link>
		<comments>http://regeneration-station.com/2008/01/22/pervasis-furthers-tissue-engineered-products-for-vascular-health/#comments</comments>
		<pubDate>Tue, 22 Jan 2008 02:30:56 +0000</pubDate>
		<dc:creator>jrowley</dc:creator>
				<category><![CDATA[Biomaterials]]></category>
		<category><![CDATA[Bioprocessing]]></category>
		<category><![CDATA[cell delivery]]></category>
		<category><![CDATA[Clinical Trials]]></category>
		<category><![CDATA[combination products]]></category>
		<category><![CDATA[Company Profiles]]></category>
		<category><![CDATA[Manufacturing]]></category>
		<category><![CDATA[Pervasis]]></category>
		<category><![CDATA[Regenerative Medicine]]></category>
		<category><![CDATA[tissue engineered product]]></category>
		<category><![CDATA[vascular regeneration]]></category>
		<category><![CDATA[end stage renal disease]]></category>
		<category><![CDATA[endothelial cells]]></category>
		<category><![CDATA[ESRD]]></category>
		<category><![CDATA[gelfoam]]></category>
		<category><![CDATA[tissue engineering]]></category>
		<category><![CDATA[vascular health]]></category>

		<guid isPermaLink="false">http://regeneration-station.com/2008/01/22/pervasis-furthers-tissue-engineered-products-for-vascular-health/</guid>
		<description><![CDATA[Pervasis Therapeutics announced that they have raised $9.75M to further develop their allogenic tissue engineered endothelial cell (EC) product for vascular health indications. Their Vascugel product is comprised of ECs grown in 3D collagen sponges that are implanted externally on blood vessels to prevent them from occluding. Pervasis has proven safety in a Phase I [...]<img alt="" border="0" src="http://stats.wordpress.com/b.gif?host=regeneration-station.com&amp;blog=2140418&amp;post=66&amp;subd=regenerationstation&amp;ref=&amp;feed=1" width="1" height="1" />]]></description>
		<wfw:commentRss>http://regeneration-station.com/2008/01/22/pervasis-furthers-tissue-engineered-products-for-vascular-health/feed/</wfw:commentRss>
		<slash:comments>1</slash:comments>
	
		<media:content url="http://0.gravatar.com/avatar/0d9b2076a0e9ca10c6e79a0e41a6caea?s=96&#38;d=identicon&#38;r=G" medium="image">
			<media:title type="html">jrowley</media:title>
		</media:content>

		<media:content url="http://regenerationstation.files.wordpress.com/2008/01/pervasis.png" medium="image">
			<media:title type="html">pervasis.png</media:title>
		</media:content>

		<media:content url="http://regenerationstation.files.wordpress.com/2008/01/pervasis-ii.png" medium="image">
			<media:title type="html">pervasis-ii.png</media:title>
		</media:content>
	</item>
		<item>
		<title>FDA Proactively Addresses Embryonic Stem Cell Safety Testing</title>
		<link>http://regeneration-station.com/2007/12/31/fda-proactively-addresses-embryonic-stem-cell-safety-testing/</link>
		<comments>http://regeneration-station.com/2007/12/31/fda-proactively-addresses-embryonic-stem-cell-safety-testing/#comments</comments>
		<pubDate>Mon, 31 Dec 2007 17:51:27 +0000</pubDate>
		<dc:creator>jrowley</dc:creator>
				<category><![CDATA[Advanced Cell Technology]]></category>
		<category><![CDATA[cell delivery]]></category>
		<category><![CDATA[Clinical Trials]]></category>
		<category><![CDATA[Embyonic Stem Cells]]></category>
		<category><![CDATA[FDA]]></category>
		<category><![CDATA[Geron]]></category>
		<category><![CDATA[Novocell]]></category>
		<category><![CDATA[Regenerative Medicine]]></category>
		<category><![CDATA[regulatory]]></category>
		<category><![CDATA[stem cells]]></category>

		<guid isPermaLink="false">http://regeneration-station.com/2007/12/31/fda-proactively-addresses-embryonic-stem-cell-safety-testing/</guid>
		<description><![CDATA[The FDA has scheduled an April 10, 2008 meeting to &#8220;discuss scientific considerations for safety testing for cellular therapy products derived from human embryonic stem cells.&#8221; This meeting will be followed by another meeting on April 11 that will &#8220;discuss updates on 1) research management related to the September 29, 2005 review of research programs [...]<img alt="" border="0" src="http://stats.wordpress.com/b.gif?host=regeneration-station.com&amp;blog=2140418&amp;post=46&amp;subd=regenerationstation&amp;ref=&amp;feed=1" width="1" height="1" />]]></description>
		<wfw:commentRss>http://regeneration-station.com/2007/12/31/fda-proactively-addresses-embryonic-stem-cell-safety-testing/feed/</wfw:commentRss>
		<slash:comments>1</slash:comments>
	
		<media:content url="http://0.gravatar.com/avatar/0d9b2076a0e9ca10c6e79a0e41a6caea?s=96&#38;d=identicon&#38;r=G" medium="image">
			<media:title type="html">jrowley</media:title>
		</media:content>

		<media:content url="http://regenerationstation.files.wordpress.com/2007/12/fda.png" medium="image">
			<media:title type="html">fda.png</media:title>
		</media:content>
	</item>
		<item>
		<title>Athersys’ Adult Stem Cell Product IND Approved for Acute MI Phase I Trial</title>
		<link>http://regeneration-station.com/2007/12/23/athersys%e2%80%99-adult-stem-cell-product-ind-approved-for-acute-mi-phase-i-trial/</link>
		<comments>http://regeneration-station.com/2007/12/23/athersys%e2%80%99-adult-stem-cell-product-ind-approved-for-acute-mi-phase-i-trial/#comments</comments>
		<pubDate>Sun, 23 Dec 2007 17:06:45 +0000</pubDate>
		<dc:creator>jrowley</dc:creator>
				<category><![CDATA[Angiotech]]></category>
		<category><![CDATA[Athersys]]></category>
		<category><![CDATA[Biomaterials]]></category>
		<category><![CDATA[cardiac regeneration]]></category>
		<category><![CDATA[cell delivery]]></category>
		<category><![CDATA[Clinical Trials]]></category>
		<category><![CDATA[Joint Ventures]]></category>
		<category><![CDATA[Regenerative Medicine]]></category>
		<category><![CDATA[cardiac cell therapy]]></category>
		<category><![CDATA[IND]]></category>

		<guid isPermaLink="false">http://regeneration-station.com/2007/12/23/athersys%e2%80%99-adult-stem-cell-product-ind-approved-for-acute-mi-phase-i-trial/</guid>
		<description><![CDATA[Athersys and their cardiac parter, Angiotech, announced today that they got the ok from the FDA to begin a Phase I clinical study using Athersys&#8217; Multistem adult stem cell product in acute myocardial infarction (MI). This is the second IND approval for Athersys in just over a month (and a welcome Christmas present for the [...]<img alt="" border="0" src="http://stats.wordpress.com/b.gif?host=regeneration-station.com&amp;blog=2140418&amp;post=43&amp;subd=regenerationstation&amp;ref=&amp;feed=1" width="1" height="1" />]]></description>
		<wfw:commentRss>http://regeneration-station.com/2007/12/23/athersys%e2%80%99-adult-stem-cell-product-ind-approved-for-acute-mi-phase-i-trial/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
	
		<media:content url="http://0.gravatar.com/avatar/0d9b2076a0e9ca10c6e79a0e41a6caea?s=96&#38;d=identicon&#38;r=G" medium="image">
			<media:title type="html">jrowley</media:title>
		</media:content>
	</item>
		<item>
		<title>CellCyte Issued Patent for Enhancing Cell Delivery to Cardiac Tissue</title>
		<link>http://regeneration-station.com/2007/11/26/cellcyte-issued-patent-for-enhancing-cell-delivery-to-cardiac-tissue/</link>
		<comments>http://regeneration-station.com/2007/11/26/cellcyte-issued-patent-for-enhancing-cell-delivery-to-cardiac-tissue/#comments</comments>
		<pubDate>Mon, 26 Nov 2007 02:14:29 +0000</pubDate>
		<dc:creator>jrowley</dc:creator>
				<category><![CDATA[cardiac regeneration]]></category>
		<category><![CDATA[cell delivery]]></category>
		<category><![CDATA[Clinical Trials]]></category>
		<category><![CDATA[Intellectual Property]]></category>
		<category><![CDATA[Regenerative Medicine]]></category>
		<category><![CDATA[stem cells]]></category>

		<guid isPermaLink="false">http://regenerationstation.wordpress.com/2007/11/26/cellcyte-issued-patent-for-enhancing-cell-delivery-to-cardiac-tissue/</guid>
		<description><![CDATA[CellCyte Genetics Corporation recently announced that US Patent No 7,282,222 was issued, a patent which they have exclusive rights to. The press release states that the patent covers unique methods and compositions “to deliver and direct stem cells to target organs in the body”, including cardiac tissue. The focus of the patent addresses cell retention [...]<img alt="" border="0" src="http://stats.wordpress.com/b.gif?host=regeneration-station.com&amp;blog=2140418&amp;post=11&amp;subd=regenerationstation&amp;ref=&amp;feed=1" width="1" height="1" />]]></description>
		<wfw:commentRss>http://regeneration-station.com/2007/11/26/cellcyte-issued-patent-for-enhancing-cell-delivery-to-cardiac-tissue/feed/</wfw:commentRss>
		<slash:comments>1</slash:comments>
	
		<media:content url="http://0.gravatar.com/avatar/0d9b2076a0e9ca10c6e79a0e41a6caea?s=96&#38;d=identicon&#38;r=G" medium="image">
			<media:title type="html">jrowley</media:title>
		</media:content>
	</item>
	</channel>
</rss>
